| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 03/01/2006 | CN1739789A Somatostation a aqua prepn and its prepn process and application |
| 03/01/2006 | CN1739781A Medicine composite for treating hyperlipemia and its prepn |
| 03/01/2006 | CN1739764A Chinese medicine for lowering blood pressure and reducing blood fat and its prepn |
| 03/01/2006 | CN1739757A Herbal formulations for modulating blood lipids |
| 03/01/2006 | CN1739730A Diabetes treating Chinese medicine prepn and its prepn process and quality control method |
| 03/01/2006 | CN1739729A Xiaokeling prepn for treating diabetes and its prepn process |
| 03/01/2006 | CN1739707A Dragon's blood extract with alpha-glycosidase inhibiting activity and its prepn making process and use |
| 03/01/2006 | CN1739657A Chinese medicine naval plaster for laxation, reducing blood fat and slimming |
| 03/01/2006 | CN1739651A Shengyi capsule with subsidiary function of reducing blood fat and its prepn |
| 03/01/2006 | CN1739626A Tea extract dripping pill |
| 03/01/2006 | CN1739605A Slimming medicine and its prepn process |
| 03/01/2006 | CN1739599A Blood fat reducing and liver protecting medicine prepared with cassia seed extract |
| 03/01/2006 | CN1739584A Phosphatide granule with subsidiary function of reducing blood fat |
| 03/01/2006 | CN1739583A Prepn process and application of Chinese medicine prepn containing Chinese torreya nut |
| 03/01/2006 | CN1739578A Instant and tablet and its prepn |
| 03/01/2006 | CN1739571A Dietotherapeutic nutrient for preventing and treating non-insulin dependent diabetes and its prepn process |
| 03/01/2006 | CN1739570A Dietotherapeutic nutrient for preventing and treating hyperglycemia and diabetes and its prepn process |
| 03/01/2006 | CN1739569A Dietotherapeutic nutrient for preventing and treating non-insulin independent diabetes and its prepn process |
| 03/01/2006 | CN1739568A Dietotherapeutic nutrient for preventing and treating adipose diabetes and its prepn process |
| 03/01/2006 | CN1739567A Dietotherapeutic nutrient for preventing and treating adipose hyperglycemia and slimming and its prepn process |
| 03/01/2006 | CN1739566A Dietotherapeutic nutrient for preventing and treating hyperglycemia and its prepn process |
| 03/01/2006 | CN1739565A Dietotheraupeutic nutrient for preventing and treating secondary diabetes and its prepn process |
| 03/01/2006 | CN1739564A Dietotherapeutic nutrient for preventing and treating diabetes and its prepn process |
| 03/01/2006 | CN1739560A Dietotherapeutic product for preventing and treating urate calculi, gout and acalcerosis and its prepn process |
| 03/01/2006 | CN1739558A Dietotherapeutic product for preventing and treating primary and secondary urate calculi, gout and acalcerosis and its prepn process |
| 03/01/2006 | CN1739557A Dietotherapeutic product for preventing and treating primary urate calculi, gout and acalcerosis and its prepn process |
| 03/01/2006 | CN1739555A Dietotherapeutic nutrient for preventing and treating non-insulin dependent hyperglycemia and obesity and its prepn process |
| 03/01/2006 | CN1739532A American ginseng-gynostemma pentaphylla total saponin prepn |
| 03/01/2006 | CN1739531A Ferric saccharate injection for treating iron-deficiency anemia and its prepn process |
| 03/01/2006 | CN1739525A Nanometer partical administration system of prostaglandin E1 coated with polyglycol derived phospholipid |
| 03/01/2006 | CN1739502A Application of benzydalysine in preparing medicine for treating diabetic peripheral neuropathy |
| 03/01/2006 | CN1739501A Coated thioctic acid tablet for treating and controlling diabetic neural lesion |
| 03/01/2006 | CN1739500A (-)-epigallocatechin gallate-magnesium complex solid dispersion and its prepn and application |
| 03/01/2006 | CN1739499A (-)-epigallocatechin gallate solid dispersion and its prepn and application |
| 03/01/2006 | CN1739493A Dispersive glimepiride tablet and its prepn process |
| 03/01/2006 | CN1739486A Fat milk injection containing carbohydrate component |
| 03/01/2006 | CN1243751C Piperidine compounds as anti-allergic medicine |
| 03/01/2006 | CN1243741C Quinolinyl and benzothiazolyc PPAR-gamma modulators |
| 03/01/2006 | CN1243740C Alpha-form or beta-form crystal of acetanilide derivative |
| 03/01/2006 | CN1243559C Herbal composition and medicament against diabetes mellitus type II manufactured thereof |
| 03/01/2006 | CN1243550C Pharmaceutical compositions and uses for androst-5-ene-3beta, 17 beta-diol and use thereof |
| 03/01/2006 | CN1243542C Composition comprising free amino acids |
| 02/28/2006 | US7005516 Derivatives of monosaccharides as cell adhesion inhibitors |
| 02/28/2006 | US7005440 Therapeutic uses of tri-aryl acid derivatives |
| 02/28/2006 | US7005436 Heterocyclo inhibitors of potassium channel function |
| 02/28/2006 | US7005433 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 02/28/2006 | US7005430 Such as (R)-2-cyclopentyl-7,8-dihydro-8-(4-picolyl)-4-(n-propyl)-1H-imidazo(2,1 -i)purin-5(4H)-one d-tartaric acid, which has glucose concentration-dependent insulin secretion promoting action/hypoglycemic activity; antidiabetic agents |
| 02/28/2006 | US7005422 Derivatives of monosaccharides as cell adhesion inhibitors |
| 02/28/2006 | US7005255 Methods for drug discovery, disease treatment, and diagnosis using metabolomics |
| 02/28/2006 | US7004945 Devices and methods for the restoration of a spinal disc |
| 02/28/2006 | CA2331877C Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 02/28/2006 | CA2251916C Additive for use in any energy supplementation, use of a protein hydrolysate to the preparation of energy supplementaton and an energy supplement containing such an additive |
| 02/23/2006 | WO2006019169A1 3-epivitamin d3 derivative and therapeutic agent containing the same |
| 02/23/2006 | WO2006018855A1 Novel antidiabetic compounds |
| 02/23/2006 | WO2006018708A2 Pyrrolidine derivatives as muscarinic receptor antagonists |
| 02/23/2006 | WO2006018280A2 Aryl-substituted polycyclic amines, method for the production thereof, and use thereof as a medicament |
| 02/23/2006 | WO2006018279A2 Aryl-substituted polycyclic amines, method for the production thereof, and use thereof as a medicament |
| 02/23/2006 | WO2006018185A2 Dihydropteridinones for the treatment of cancer diseases |
| 02/23/2006 | WO2006018117A1 Substituted 8-aminoalkoxi-xanthines, method for the production thereof and use thereof as medicaments |
| 02/23/2006 | WO2006018116A1 N-(phenyl-oxazol-4-ylmethoxymethyl)-cyclohexyl-succinic acid amide derivatives and related compounds which are used as ppar-ligands (peroxisome proliferator-activated receptors) for the treatment of hyperlipidaemie and diabetes |
| 02/23/2006 | WO2005110980A3 Aryl sulfones and uses related thereto |
| 02/23/2006 | US20060041164 liver X receptor LXR agonists; increasing ABCA1, ABCG1, and apolipoprotein E expression, increasing cholesterol efflux from peripheral cells, cardiovascular disease, inflammation; 2-(3-{3-[[2-Chloro-3-(trifluoromethyl)benzyl](2,2-diphenylethyl)amino]-2-methyl-propoxy}-phenyl)acetic acid methyl ester |
| 02/23/2006 | US20060041139 Antagonists for melanin concentrating hormone-1 receptors; antidepressants, anxiolytic agents; incontinence, obesity |
| 02/23/2006 | US20060041007 Metastable benzoxepne derivatives which can be used in the treatment of dyslipidaemia a therosclerosis and diabetes, pharmaceutical compositions comprising them and processes for the preparation thereof |
| 02/23/2006 | US20060040993 Having (i) an infra red spectrum containing peaks at 1549, 759, 600 cm-1; (ii) a Raman spectrum containing peaks at 1338, 1183, 990, 552 cm-1; and/or (iii) an X-ray powder diffraction pattern containing peaks at 6.2, 11.9, 15.9, 19.8, 22.7 degrees 2 theta . |
| 02/23/2006 | US20060040989 N-aryl piperidine substituted biphenylcarboxamides as inhibitors of apolipoprotein b secretion |
| 02/23/2006 | US20060040979 3-Aryl-2-hydroxypropionic acid derivative I |
| 02/23/2006 | US20060040969 Drug combinations comprising (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl] (3R,5S)-3,5-dihydroxyhept-6-enoic acid and an inhibitor, inducer or substrate of P450 isoenzyme 3A4 |
| 02/23/2006 | US20060040964 Eating disorders; psychological disorders; antidiabetic agents; cardiovascular disorders |
| 02/23/2006 | US20060040963 Piperidino pyrimidine dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 02/23/2006 | US20060040912 Compounds for pdt |
| 02/23/2006 | US20060040906 Piperazine urea derivatives as melanocortin-4 receptor agonists |
| 02/23/2006 | US20060040876 Modulation of peroxisome proliferator-activated receptors |
| 02/23/2006 | US20060040851 Gag-peptide complex |
| 02/23/2006 | US20060039974 Sustained release preparation |
| 02/23/2006 | US20060039962 Amphiphilic compounds and vesicles liposomes for organ-specified drug targeting |
| 02/23/2006 | US20060039932 Application of phytosteroids (and isomers thereof), folic acid, cyanocobalamine and pyridoxine in dietetic (alimentary) fibers |
| 02/23/2006 | US20060039918 Stress proteins and peptides and methods of use thereof |
| 02/23/2006 | US20060039903 Immunomodulation and effect on cell processes relating to serotonin family receptors |
| 02/23/2006 | DE10309929B4 Substituierte Benzoylureidopyridyl-piperidin- und -pyrrolidin-carbonsäurederivate, Verfahren zu deren Herstellung und deren Verwendung Benzoylureidopyridyl substituted-piperidine and -pyrrolidine carboxylic acid derivatives, processes for their preparation and their use |
| 02/23/2006 | DE102004039096A1 New D-xylopyranosyl-phenyl-substituted cycle compounds useful for treating e.g. diabetes mellitus, complications of diabetes, metabolic acidosis or ketosis |
| 02/23/2006 | DE102004036047A1 Physiologisch aktive Zusammensetzung Physiologically active composition |
| 02/23/2006 | CA2577668A1 Novel antidiabetic compounds |
| 02/23/2006 | CA2577261A1 Aryl-substituted polycyclic amines, method for the production thereof, and use thereof as a medicament |
| 02/23/2006 | CA2577255A1 Aryl-substituted polycyclic amines, method for the production thereof, and use thereof as a medicament |
| 02/23/2006 | CA2577169A1 Metabolism-modulating agents and uses therefor |
| 02/23/2006 | CA2576860A1 Methods for modulating lipoprotein and cholesterol levels in human |
| 02/23/2006 | CA2576584A1 2 - {-3-`2-(phenyl)-oxazol-4-ylmethoxymethyl!-cyclohexylmethoxy}-propionic acid derivatives used as ppar ligandes (peroxisome proliferator-activated receptors) for the treatment of hyperlipidaemie and diabetes |
| 02/23/2006 | CA2576561A1 Substituted 8-aminoalkoxi-xanthines, method for the production thereof and use thereof as medicaments |
| 02/23/2006 | CA2576554A1 N-(phenyl-oxazol-4-ylmethoxymethyl)-cyclohexyl-succinic acid amide derivatives and related compounds which are used as ppar-ligands (peroxisome proliferator-activated receptors) for the treatment of hyperlipidaemie and diabetes |
| 02/23/2006 | CA2576545A1 2 - { - 3 2 - (phenyl)-oxazol-4-ylmethoxyl-cyclohexylmethoxy}-propionic acid derivatives used as ppar ligands (peroxisome proliferator-activated receptors) for the treatment of hyperlipidaemie and diabetes |
| 02/23/2006 | CA2576091A1 Indole derivatives comprising an acetylene group as ppar activators |
| 02/23/2006 | CA2575787A1 Dihydropteridinones for the treatment of cancer diseases |
| 02/23/2006 | CA2575563A1 Combination therapy for diabetes, obesity, and cardiovascular diseases using gdf-8 inhibitors |
| 02/23/2006 | CA2573772A1 Heterocyclyls as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders |
| 02/23/2006 | CA2573761A1 Use of estrogen related receptor-modulating aryl ethers |
| 02/22/2006 | EP1627875A1 Method for producing cyclic diamine derivative or salt thereof |
| 02/22/2006 | EP1627870A1 Cyanofluoropyrrolidine derivative |
| 02/22/2006 | EP1627869A1 Amide derivative |
| 02/22/2006 | EP1627866A1 Carboxylic acid compound and medicine containing the same |